Incyte Biosciences International Sàrl - Iclusig 45 mg, comprimés pelliculés | | 63097 | | 02 | | Iclusig 45 mg | | comprimés pelliculés | | L01EA05 | | Ponatinib | | 12.02.2014 | | |
| Composition | ponatinibum 40 mg ut ponatinibi hydrochloridum, lactosum monohydricum 120.45 mg, cellulosum microcristallinum, carboxymethylamylum natricum corresp. natrium 0.528 mg, silica colloidalis anhydrica, magnesii stearas, pellicule: talcum, macrogolum 4000, poly(alcohol vinylicus), E 171, pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Ponatinibum | 40 mg |
| BAG: Active Agent | Dose |
---|
Ponatinibum | 45 mg |
| | Inactive agents | Dose | additional_information |
---|
Carboxymethylamylum Natricum | | | Cellulosum Microcristallinum | | | E 171 | | color. | Lactose Monohydrate | 120.45 mg | | Macrogol | 4000 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) | | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | pellicule |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 30 Tablet(s) | 4854.18 | 5288.20 | A | SL | Yes | 004 | 90 Tablet(s) | PR | PR | A | | Yes |
|
|